Identity
Other names: ASPL (Alveolar soft part sarcoma locus) HGNC (Hugo): ASPSCR1 Location: 17q25 
Transcription
Alternative splicing of 47 bp from exon 2 in the 5' untranslated region.
Protein
Description 476 amino acids; contains an UBX domain, which may be related to the ubiquitylation pathway.
Expression
Widely expressed in the adult; low expression in fetal tissues.
Implicated in

Alveolar soft part sarcoma with ASPSCR1 -TFE3 fusion
Cytogenetics der(X)t(X;17)(p11;q25) is consistently involved; it implicates: 1-the formation of a hybrid gene at the breakpoint, and also, 2-gain in Xp11-pter sequences, and loss of heterozygocity in 11q25-qter, with possible implications. Hybrid/Mutated gene 5' ASPSCR1-3' TFE3; the reciprocal 5' TFE3 -3' ASPSCR1 is most often absent. ASPSCR1 is fused in frame to TFE3 exon 3 or 4. Abnormal protein NH2 term ASPSCR1, fused to the C term of TFE3. Oncogenesis Might combine the effect of a fusion protein to that of gene(s) dosage.
Primary renal ASPSCR1-TFE3 tumour
Disease A subset of renal cell carcinoma, which presents with a combination of alveolar soft part sarcoma-like features and epithelial features is found to carry this anomaly. Cytogenetics Balanced t(X;17)(p11.2;q25), in contrast with what is found in the alveolar soft part sarcoma (see above). Hybrid/Mutated gene 5' ASPSCR1-3' TFE3. Abnormal protein NH2 term ASPSCR1, fused to the C term of TFE3.
